Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Cervical Cancer

  Free Subscription


1 ACS Nano
1 Altern Ther Health Med
1 Am J Surg Pathol
1 Arch Gynecol Obstet
1 Arch Sex Behav
1 Biomed Opt Express
1 Biomed Phys Eng Express
1 BMC Biol
1 BMC Cancer
1 BMC Public Health
2 BMC Womens Health
1 BMJ Sex Reprod Health
1 Brachytherapy
1 Bull Math Biol
1 Cancer Res Treat
5 Cancers (Basel)
1 Cell Biochem Funct
1 Clin Oncol (R Coll Radiol)
1 Cureus
1 Curr Cancer Drug Targets
2 Discov Oncol
1 Epigenomics
1 Eur J Med Chem
1 Eur J Obstet Gynecol Reprod Biol
1 Eur J Surg Oncol
1 Eur Radiol
1 Food Sci Nutr
1 Front Immunol
1 Front Oncol
1 Geburtshilfe Frauenheilkd
1 Georgian Med News
1 Gynecol Obstet Invest
1 Gynecol Oncol Rep
1 Health Promot J Austr
1 Health Promot Perspect
1 Healthcare (Basel)
1 Infect Agent Cancer
1 Int J Biol Sci
1 Int J Cancer
2 Int J Gynaecol Obstet
1 Int J Mol Sci
1 Int J Radiat Oncol Biol Phys
1 Ir J Med Sci
1 J Appl Clin Med Phys
1 J Cancer Res Clin Oncol
1 J Int AIDS Soc
1 J Med Case Rep
1 J Med Virol
1 J Transcult Nurs
1 JMIR Public Health Surveill
1 Jpn J Radiol
1 Lancet Oncol
1 mBio
1 Med
2 Medicine (Baltimore)
1 Minerva Obstet Gynecol
1 Molecules
1 Photodiagnosis Photodyn Ther
1 PLOS Glob Public Health
2 PLoS One
1 Prev Med Rep
1 Proc Natl Acad Sci U S A
1 Public Health Nurs
1 Radiat Oncol
2 Sci Rep
1 Transl Cancer Res
2 Virchows Arch

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    ACS Nano

  1. WANG Y, Lv B, Wang H, Ren T, et al
    Ultrasound-Triggered Azo Free Radicals for Cervical Cancer Immunotherapy.
    ACS Nano. 2024 Apr 16. doi: 10.1021/acsnano.3c10625.
    PubMed         Abstract available

    Altern Ther Health Med

  2. ZHANG G, Su G
    Efficacy and Safety of Recombinant Human p53 Adenovirus Injection Combined with Radiotherapy or Concurrent Chemoradiotherapy in the Treatment of Cervical Cancer: A Systematic Review and Meta-analysis.
    Altern Ther Health Med. 2024 Apr 18:AT10189.
    PubMed         Abstract available

    Am J Surg Pathol

  3. RUIZ F, Tjendra Y, Millan N, Gomez-Fernandez C, et al
    Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
    Am J Surg Pathol. 2024 Feb 15. doi: 10.1097/PAS.0000000000002193.
    PubMed         Abstract available

    Arch Gynecol Obstet

  4. PERGIALIOTIS V, Papageorgiou D, Douligeris A, Mortaki A, et al
    Awareness, knowledge and attitudes of human papillomavirus infection, screening and vaccination: a survey study in Greece.
    Arch Gynecol Obstet. 2024;309:2031-2040.
    PubMed         Abstract available

    Arch Sex Behav

  5. SPENCER JC, Charlton BM, Pretsch PK, Schnarrs PW, et al
    Barriers to Cervical Cancer Screening by Sexual Orientation Among Low-Income Women in North Carolina.
    Arch Sex Behav. 2024 Apr 16. doi: 10.1007/s10508-024-02844.
    PubMed         Abstract available

    Biomed Opt Express

  6. LIU C, Yuan Z, Liu Q, Song K, et al
    Siamese deep learning video flow cytometry for automatic and label-free clinical cervical cancer cell analysis.
    Biomed Opt Express. 2024;15:2063-2077.
    PubMed         Abstract available

    Biomed Phys Eng Express

  7. DEO BS, Nayak S, Pal M, Panigrahi PK, et al
    Wavelet scattering transform and entropy features in fluorescence spectral signal analysis for cervical cancer diagnosis.
    Biomed Phys Eng Express. 2024 Apr 18. doi: 10.1088/2057-1976.
    PubMed         Abstract available

    BMC Biol

  8. ZHANG Y, Lei Y, Ou Q, Chen M, et al
    Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway.
    BMC Biol. 2024;22:88.
    PubMed         Abstract available

    BMC Cancer

  9. GU Z, Yang C, Zhang K, Wu H, et al
    Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer.
    BMC Cancer. 2024;24:492.
    PubMed         Abstract available

    BMC Public Health

  10. OKYERE J, Ayebeng C, Dosoo AK, Dickson KS, et al
    Cervical cancer screening among women with comorbidities: evidence from the 2022 Tanzania demographic and health survey.
    BMC Public Health. 2024;24:1093.
    PubMed         Abstract available

    BMC Womens Health

  11. XU M, Lin MC, Li ZH
    Interferon-gamma-induced GBP1 is an inhibitor of human papillomavirus 18.
    BMC Womens Health. 2024;24:240.
    PubMed         Abstract available

  12. TAKAGAWA Y, Izumi S, Takahashi E, Kita M, et al
    Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report.
    BMC Womens Health. 2024;24:249.
    PubMed         Abstract available

    BMJ Sex Reprod Health

  13. HAWKINS KE, Gourlay K, Cuschieri K
    Challenges for cervical screening in people experiencing homelessness.
    BMJ Sex Reprod Health. 2024;50:150-151.


  14. KASHID SR, Gurram L, Pullan S, Chopra S, et al
    Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data.
    Brachytherapy. 2024 Apr 18:S1538-4721(24)00047.
    PubMed         Abstract available

    Bull Math Biol

  15. WANG Z, Cho H, Choyke P, Levy D, et al
    A Mathematical Model of TCR-T Cell Therapy for Cervical Cancer.
    Bull Math Biol. 2024;86:57.
    PubMed         Abstract available

    Cancer Res Treat

  16. TRAN TXM, Kim S, Cha C, Park B, et al
    Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer.
    Cancer Res Treat. 2024;56:522-530.
    PubMed         Abstract available

    Cancers (Basel)

  17. JACQUES C, Marchand F, Chatelais M, Albinet V, et al
    The Micro-Immunotherapy Medicine 2LPAPI((R)) Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer C
    Cancers (Basel). 2024;16:1421.
    PubMed         Abstract available

  18. BEBIA V, Diaz-Feijoo B, Tejerizo A, Torne A, et al
    Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?
    Cancers (Basel). 2024;16:1423.
    PubMed         Abstract available

  19. LE GUEVELOU J, Selleret L, Laas E, Lecuru F, et al
    Cervical Cancer Associated with Pregnancy: Current Challenges and Future Strategies.
    Cancers (Basel). 2024;16:1341.
    PubMed         Abstract available

  20. BELLOSILLO B, Ibanez R, Roura E, Monfil L, et al
    Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening.
    Cancers (Basel). 2024;16:1322.
    PubMed         Abstract available

  21. BALCIUNIENE E, Inciura A, Juozaityte E, Ugenskiene R, et al
    Impact of RRP1B Variants on the Phenotype, Progression, and Metastasis of Cervical Cancer.
    Cancers (Basel). 2024;16:1250.
    PubMed         Abstract available

    Cell Biochem Funct

  22. MARIN-AQUINO LA, Mora-Garcia ML, Moreno-Lafont MC, Garcia-Rocha R, et al
    Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A(2A)R/A(2B)R and the production of TGF-beta1.
    Cell Biochem Funct. 2024;42:e4010.
    PubMed         Abstract available

    Clin Oncol (R Coll Radiol)

  23. WU Z, Jia X, Lu L, Xu C, et al
    Multi-center Dose Prediction Using Attention-aware Deep learning Algorithm Based on Transformers for Cervical Cancer Radiotherapy.
    Clin Oncol (R Coll Radiol). 2024 Mar 26:S0936-6555(24)00119.
    PubMed         Abstract available


  24. ZHANG R, Xu W, Yang S, Hu D, et al
    Prevalence of High-Risk Human Papillomavirus Infection, Associated Risk Factors, and Relationship With Cervical Precancerous Lesions in Perimenopausal and Older Women in an Area With High Cervical Cancer Incidence in China.
    Cureus. 2024;16:e58081.
    PubMed         Abstract available

    Curr Cancer Drug Targets

  25. HERNANDEZ-PADILLA L, Duran-Maldonado MX, Martinez-Alcantar L, Rodriguez-Zavala JS, et al
    The HGF/Met Receptor Mediates Cytotoxic Effect of Bacterial Cyclodipeptides in Human Cervical Cancer Cells.
    Curr Cancer Drug Targets. 2024 Apr 15. doi: 10.2174/0115680096285034240323035013
    PubMed         Abstract available

    Discov Oncol

  26. TIAN W, Tan S, Wang J, Shen P, et al
    Immune-related LncRNAs scores predicts chemotherapeutic responses and prognosis in cervical cancer patients.
    Discov Oncol. 2024;15:119.
    PubMed         Abstract available

  27. HUANG Y, Pan C, Wu S, Ye F, et al
    A combination of cuproptosis and lncRNAs predicts the prognosis and tumor immune microenvironment in cervical cancer.
    Discov Oncol. 2024;15:116.
    PubMed         Abstract available


  28. HU J, Wang S, Li X
    A comprehensive review of m(6)A research in cervical cancer.
    Epigenomics. 2024 Apr 19. doi: 10.2217/epi-2024-0002.
    PubMed         Abstract available

    Eur J Med Chem

  29. LI SS, Chen JJ, Zhang MM, Wang WX, et al
    Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition.
    Eur J Med Chem. 2024;271:116425.
    PubMed         Abstract available

    Eur J Obstet Gynecol Reprod Biol

  30. LIU S, Zhang W, Wang W, Zheng J, et al
    Topical delivery of drugs in the treatment of high-grade cervical squamous intraepithelial lesions: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:131-139.
    PubMed         Abstract available

    Eur J Surg Oncol

  31. BUCHALET C, Loap P, Losa S, Laas E, et al
    Long-term clinical outcomes of preoperative brachytherapy in early-stage cervical cancer.
    Eur J Surg Oncol. 2024;50:108342.
    PubMed         Abstract available

    Eur Radiol

  32. LIU K, Yang W, Tian H, Li Y, et al
    Association between programmed cell death ligand-1 expression in patients with cervical cancer and apparent diffusion coefficient values: a promising tool for patient s immunotherapy selection.
    Eur Radiol. 2024 Apr 18. doi: 10.1007/s00330-024-10759.
    PubMed         Abstract available

    Food Sci Nutr

  33. YIFAN M, Rui X, Yuan L, Feiyun J, et al
    Allicin inhibits the biological activities of cervical cancer cells by suppressing circEIF4G2.
    Food Sci Nutr. 2024;12:2523-2536.
    PubMed         Abstract available

    Front Immunol

  34. CHOI CH, Lee JW, Bae DS, Kang ES, et al
    Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
    Front Immunol. 2024;15:1371353.
    PubMed         Abstract available

    Front Oncol

  35. MA Y, Zhao X, Chen X
    Contrast-enhanced ultrasound combined with elastic imaging for predicting the efficacy of concurrent chemoradiotherapy in cervical cancer: a feasibility study.
    Front Oncol. 2024;14:1301900.
    PubMed         Abstract available

    Geburtshilfe Frauenheilkd

  36. SONG L, Gao Y, Wang Z, Shi Y, et al
    Serum Levels of Intercellular Adhesion Molecule 1 and Vascular Cell Adhesion Molecule 1 as Biomarkers to Predict Radiotherapy Sensitivity in Cervical Cancer.
    Geburtshilfe Frauenheilkd. 2024;84:370-377.
    PubMed         Abstract available

    Georgian Med News

  37. VOVK V, Duda I, Vovk A
    Georgian Med News. 2024;:41-46.
    PubMed         Abstract available

    Gynecol Obstet Invest

  38. GARDELLA B, Dominoni M, Pasquali MF, Gotti M, et al
    Retrospective Investigation of Human Papillomavirus Cervical Infection and Lymphoma Incidence: A Clinical and Pathological Evaluation.
    Gynecol Obstet Invest. 2024;89:95-102.
    PubMed         Abstract available

    Gynecol Oncol Rep

  39. SHA S, R J Goyette E, West LA, Bentz JL, et al
    Recurrent pembrolizumab-induced mechanical small bowel obstruction in a patient with metastatic cervical cancer.
    Gynecol Oncol Rep. 2024;53:101382.
    PubMed         Abstract available

    Health Promot J Austr

  40. TEMMINGHOFF L, Russell C, Andersson T, Broun K, et al
    Barriers and enablers to participation in the National Cervical Screening Program experienced by young women and people with a cervix aged between 25 and 35.
    Health Promot J Austr. 2024;35:376-384.
    PubMed         Abstract available

    Health Promot Perspect

  41. SHARIATI SARCHESHME M, Mahdizadeh M, Tehrani H, Vahedian-Shahroodi M, et al
    Exploring the barriers to Pap smear test compliance: A qualitative study for improving cervical cancer screening in the primary health care.
    Health Promot Perspect. 2024;14:80-88.
    PubMed         Abstract available

    Healthcare (Basel)

  42. OZTURK NY, Hossain SZ, Mackey M, Adam S, et al
    HPV and Cervical Cancer Awareness and Screening Practices among Migrant Women: A Narrative Review.
    Healthcare (Basel). 2024;12:709.
    PubMed         Abstract available

    Infect Agent Cancer

  43. SHEN J, Sun H, Chu J, Gong X, et al
    Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer.
    Infect Agent Cancer. 2024;19:13.
    PubMed         Abstract available

    Int J Biol Sci

  44. LIU P, Xie L, Wu Q, Huang L, et al
    TIE1 promotes cervical cancer progression via Basigin-matrix metalloproteinase axis.
    Int J Biol Sci. 2024;20:2297-2309.
    PubMed         Abstract available

    Int J Cancer

  45. WEN TM, Xu XQ, Zhao XL, Pan CH, et al
    Efficacy and immunogenicity of AS04-HPV-16/18 vaccine in females with existing cervical HR-HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide.
    Int J Cancer. 2024 Feb 17. doi: 10.1002/ijc.34882.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  46. LUCKETT R, Ramogola-Masire D, Gompers A, Moraka N, et al
    Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana.
    Int J Gynaecol Obstet. 2023 Nov 10. doi: 10.1002/ijgo.15225.
    PubMed         Abstract available

  47. HILL SK, Bempong-Ahun N, Okolo ID, Lalla AT, et al
    Improving access to safe, quality surgical care for gynecologic cancers through capacity-building interventions in low- and middle-income countries: A scoping review.
    Int J Gynaecol Obstet. 2023 Nov 5. doi: 10.1002/ijgo.15156.
    PubMed         Abstract available

    Int J Mol Sci

  48. AGUILAR-MARTINEZ SY, Campos-Viguri GE, Medina-Garcia SE, Garcia-Flores RJ, et al
    MiR-21 Regulates Growth and Migration of Cervical Cancer Cells by RECK Signaling Pathway.
    Int J Mol Sci. 2024;25:4086.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  49. COLSON-FEARON D, Han K, Roumeliotis MB, Viswanathan AN, et al
    Updated Trends in Cervical Cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
    Int J Radiat Oncol Biol Phys. 2024;119:154-162.
    PubMed         Abstract available

    Ir J Med Sci

  50. ZHOU L, Bi Y, Wu X, He H, et al
    High keratin 15 expression reflects favorable prognosis in early cervical cancer patients.
    Ir J Med Sci. 2024 Apr 19. doi: 10.1007/s11845-024-03686.
    PubMed         Abstract available

    J Appl Clin Med Phys

  51. DOUGLAS R, Olanrewaju A, Mumme R, Zhang L, et al
    Evaluating automatically generated normal tissue contours for safe use in head and neck and cervical cancer treatment planning.
    J Appl Clin Med Phys. 2024 Apr 12:e14338. doi: 10.1002/acm2.14338.
    PubMed         Abstract available

    J Cancer Res Clin Oncol

  52. WANG N, Xu J, Wang Y, Zhang X, et al
    USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination.
    J Cancer Res Clin Oncol. 2024;150:196.
    PubMed         Abstract available

    J Int AIDS Soc

  53. WAMUTI B, Jamil MS, Siegfried N, Ford N, et al
    Understanding effective post-test linkage strategies for HIV prevention and care: a scoping review.
    J Int AIDS Soc. 2024;27:e26229.
    PubMed         Abstract available

    J Med Case Rep

  54. LIN W, Yao B, He J, Lin S, et al
    The effect of physical therapy and mechanical stimulation on dysfunction of lower extremities after total pelvic exenteration in cervical carcinoma patient with rectovesicovaginal fistula induced by radiotherapy: a case report.
    J Med Case Rep. 2024;18:207.
    PubMed         Abstract available

    J Med Virol

  55. LAURIE C, El-Zein M, Tota JE, Tellier PP, et al
    Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) trial.
    J Med Virol. 2024;96:e29604.
    PubMed         Abstract available

    J Transcult Nurs

  56. LIU XQ, Wang L, Gu X, Shan X, et al
    The Experience of Cervical Cancer Patients Undergoing Hysterectomy: A Qualitative Study.
    J Transcult Nurs. 2024 Apr 18:10436596241246976. doi: 10.1177/10436596241246976.
    PubMed         Abstract available

    JMIR Public Health Surveill

  57. CHEN YC, Chen YY, Su SY, Jhuang JR, et al
    Projected Time for the Elimination of Cervical Cancer Under Various Intervention Scenarios: Age-Period-Cohort Macrosimulation Study.
    JMIR Public Health Surveill. 2024;10:e46360.
    PubMed         Abstract available

    Jpn J Radiol

  58. ITO K, Nakajima Y, Ogawa H, Furusawa A, et al
    Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy.
    Jpn J Radiol. 2024 Apr 16. doi: 10.1007/s11604-024-01566.
    PubMed         Abstract available

    Lancet Oncol

  59. OAKNIN A, Moore K, Meyer T, Lopez-Picazo Gonzalez J, et al
    Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
    Lancet Oncol. 2024 Apr 9:S1470-2045(24)00088.
    PubMed         Abstract available


  60. YU L, Majerciak V, Lobanov A, Mirza S, et al
    HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer.
    mBio. 2024 Apr 16:e0072924. doi: 10.1128/mbio.00729.
    PubMed         Abstract available


  61. KNISELY A, Hinchcliff E, Fellman B, Mosley A, et al
    Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis.
    Med. 2024;5:311-320.
    PubMed         Abstract available

    Medicine (Baltimore)

  62. XIAO Y, Yu R, Gu J
    Diagnosis and rescue of malignant hyperthermia induced by anesthesia during radical surgery in a cervical cancer patient using the National Remote Emergency System: A case report.
    Medicine (Baltimore). 2024;103:e37699.
    PubMed         Abstract available

  63. CHEN XX, Nie C, Rao DF, Chen XX, et al
    The effect of refined psychological pain nursing combined with IMB nursing on the pain, sleep and quality of life of patients after cervical cancer surgery.
    Medicine (Baltimore). 2024;103:e37816.
    PubMed         Abstract available

    Minerva Obstet Gynecol

  64. FLORENCE AM, Fogel J, Mozey M, Dave S, et al
    Therapeutic human papilloma virus vaccination in patients at risk for cervical dysplasia.
    Minerva Obstet Gynecol. 2024;76:127-134.
    PubMed         Abstract available


  65. PANTE GC, Castro JC, Lini RS, Romoli JCZ, et al
    Inclusion Complexes of Litsea cubeba (Lour.) Pers Essential Oil into beta-Cyclodextrin: Preparation, Physicochemical Characterization, Cytotoxicity and Antifungal Activity.
    Molecules. 2024;29:1626.
    PubMed         Abstract available

    Photodiagnosis Photodyn Ther

  66. YAN Z, Chang C, Kang Z, Chen C, et al
    Application of one-dimensional hierarchical network assisted screening for cervical cancer based on Raman spectroscopy combined with attention mechanism.
    Photodiagnosis Photodyn Ther. 2024 Apr 10:104086.
    PubMed         Abstract available

    PLOS Glob Public Health

  67. MAPAONA R, Williams V, Musarapasi N, Kibwana S, et al
    Cervical cancer screening outcomes for HIV-positive women in the Lubombo and Manzini regions of Eswatini-Prevalence and predictors of a positive visual inspection with acetic acid (VIA) screen.
    PLOS Glob Public Health. 2024;4:e0002760.
    PubMed         Abstract available

    PLoS One

  68. KHUMALO PG, Carey M, Mackenzie L, Sanson-Fisher R, et al
    Cervical cancer screening knowledge and associated factors among Eswatini women: A cross-sectional study.
    PLoS One. 2024;19:e0300763.
    PubMed         Abstract available

  69. DUA R, Bhardwaj T, Ahmad I, Somvanshi P, et al
    Investigating the potential of Juglans regia phytoconstituents for the treatment of cervical cancer utilizing network biology and molecular docking approach.
    PLoS One. 2024;19:e0287864.
    PubMed         Abstract available

    Prev Med Rep

  70. LI E, Ni H
    Prognostic nomogram for early-stage cervical cancer in the elderly: A SEER database analysis.
    Prev Med Rep. 2024;41:102700.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  71. BELLONE S, Jeong K, Halle MK, Krakstad C, et al
    Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Proc Natl Acad Sci U S A. 2024;121:e2321898121.
    PubMed         Abstract available

    Public Health Nurs

  72. LUO Y, Liu T, Yang X, Lu M, et al
    Human papillomavirus vaccination and contributing factors of vaccination intention among adolescents and young adults in China from a socio-ecological perspective: A cross-sectional study.
    Public Health Nurs. 2024;41:602-616.
    PubMed         Abstract available

    Radiat Oncol

  73. ZENG Z, Zhu J, Wang Z, Wang G, et al
    Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography.
    Radiat Oncol. 2024;19:48.
    PubMed         Abstract available

    Sci Rep

  74. CHO O, Chun M, Chang SJ
    Average log change rate of pretreatment squamous cell carcinoma antigen after concurrent chemoradiotherapy in stage IIIC1 cervical squamous cell carcinoma.
    Sci Rep. 2024;14:8710.
    PubMed         Abstract available

  75. GRINCEVICIENE S, Vaitkiene D, Kanopiene D, Vanseviciute Petkeviciene R, et al
    Aerobic vaginitis is associated with carbonic anhydrase IX in cervical intraepithelial neoplasia.
    Sci Rep. 2024;14:8789.
    PubMed         Abstract available

    Transl Cancer Res

  76. JIN L, Cao F, Zhang Y, Dang Y, et al
    Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer.
    Transl Cancer Res. 2024;13:1323-1335.
    PubMed         Abstract available

    Virchows Arch

  77. BRITO MJ, Sequeira P, Quintas A, Silva I, et al
    Programmed death-ligand 1 (PD-L1) expression in cervical intraepithelial neoplasia and cervical squamous cell carcinoma of HIV-infected and non-infected patients.
    Virchows Arch. 2024;484:507-516.
    PubMed         Abstract available

  78. SZALAI L, Vereczkey I, Szemes M, Rokusz A, et al
    NTRK-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::NTRK1 fusion.
    Virchows Arch. 2024;484:527-531.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.